SCHEMBL29177226

SCHEMBL29177226

Cc1cc(F)c(OC(N)=O)cc1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.35
▸ CD44 P16070 1/20 0.35
▸ KDM4E B2RXH2 3/20 0.35
▸ ALDH1A1 P00352 3/20 0.35
▸ LMNA P02545 3/20 0.35
▸ MAPT P10636 3/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ CYP1A2 P05177 1/20 0.34
▸ NPSR1 Q6W5P4 2/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ CYP11B1 P15538 1/20 0.33
▸ CYP11B2 P19099 1/20 0.33
▸ CA12 O43570 3/20 0.33
▸ CA1 P00915 3/20 0.33
▸ CA2 P00918 3/20 0.33
▸ CA9 Q16790 3/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26090166 0.93 CD44 (0.35) SMN1; SMN2CD44KDM4EALDH1A1LMNA
SCHEMBL29177402 0.85 MEN1 (0.36) LMNAMEN1KMT2ARAB9A
SCHEMBL29177288 0.84 CD44 (0.39) SMN1; SMN2CD44KDM4EALDH1A1LMNA
SCHEMBL29177282 0.84 CD44 (0.39) SMN1; SMN2CD44KDM4EALDH1A1LMNA
SCHEMBL25295762 0.84 CYP1A2 (0.36) ALDH1A1MEN1KMT2ACYP1A2CYP11B1
SCHEMBL29177199 0.84 MEN1 (0.35) LMNAMEN1KMT2ARAB9A
SCHEMBL29177373 0.79 SMN1; SMN2 (0.47) SMN1; SMN2KDM4EALDH1A1LMNAMAPT
SCHEMBL29227718 0.79 MEN1 (0.32) LMNAMEN1KMT2ARAB9A
SCHEMBL29177188 0.79 LMNA (0.41) SMN1; SMN2LMNACYP1A2RAB9A
SCHEMBL28645960 0.79 MEN1 (0.36) LMNAMAPTMEN1KMT2ANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117242060-A Isoindolinone compounds 蒙特罗萨医疗公司 2023-12-15 — — CN disclosed
Send feedback